Otenabant
Chemical compound / From Wikipedia, the free encyclopedia
Otenabant (CP-945,598) is a drug that acts as a potent and highly selective CB1 antagonist.[1] It was developed by Pfizer for the treatment of obesity,[2] but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.[3]
Quick Facts Clinical data, ATC code ...
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H25Cl2N7O |
Molar mass | 510.42 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close